We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
-11.33%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
–
AUM
$380M
AUM Growth
-$27.7M
Cap. Flow
+$34M
Cap. Flow %
8.94%
Top 10 Hldgs %
74.09%
Holding
57
New
15
Increased
8
Reduced
9
Closed
10

Top Buys

Rank Stock Value
1
TGAN
Transphorm, Inc. Common Stock
TGAN
+$24.1M
2
MTRN icon
Materion
MTRN
+$14.6M
3
SEV
Sono Group N.V. Common Shares
SEV
+$13.6M
4
ANIP icon
ANI Pharmaceuticals
ANIP
+$7.05M
5
AIRG icon
Airgain
AIRG
+$6.56M

Top Sells

Rank Stock Value
1
PDFS icon
PDF Solutions
PDFS
+$24M
2
SIMO icon
Silicon Motion
SIMO
+$21.9M
3
PLAB icon
Photronics
PLAB
+$20.7M
4
EOLS icon
Evolus
EOLS
+$11M
5
FOCL
EDAP TMS S.A.
FOCL
+$4.55M

Sector Composition

Rank Sector Weight
1 Technology 30.49%
2 Healthcare 19.16%
3 Materials 3.52%
4 Industrials 1.09%
5 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VCNX
26
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$2.25M 0.59%
9,913
– –
ARDX icon
27
Ardelyx
ARDX
$1.24B
$2.23M 0.59%
3,773,421
+658,819
+21% +$485K
TELA icon
28
TELA Bio
TELA
$40.6M
$2.16M 0.57%
+306,464
New +$2.54M
EOLS icon
29
Evolus
EOLS
$403M
$2M 0.53%
172,592
-928,648
-84% -$11M
CLRB icon
30
Cellectar Biosciences
CLRB
$20.5M
$1.63M 0.43%
6,123
– –
RNAZ icon
31
TransCode Therapeutics
RNAZ
$4.71M
$1.62M 0.43%
+2
New +$3.22M
FKWL icon
32
Franklin Wireless
FKWL
$26.8M
$1.24M 0.33%
390,000
+291,174
+295% +$1.02M
CNTX icon
33
Context Therapeutics
CNTX
$57.1M
$1.19M 0.31%
+1,191,771
New +$2.23M
SLNO
34
DELISTED
Soleno Therapeutics
SLNO
$1.18M 0.31%
424,090
-29,243
-6% -$81K
NBSE
35
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$1.08M 0.28%
51,379
– –
MYO icon
36
Myomo
MYO
$41.7M
$1.04M 0.27%
617,179
– –
SVRE
37
SaverOne 2014 Ltd
SVRE
$6.02M
$1.03M 0.27%
+52
New +$1.13M
BW icon
38
Babcock & Wilcox
BW
$1.51B
$984K 0.26%
+163,199
New +$1.14M
XFOR icon
39
X4 Pharmaceuticals
XFOR
$405M
$962K 0.25%
33,257
– –
PCSA icon
40
Processa Pharmaceuticals
PCSA
$5.87M
$853K 0.22%
607
– –
RZLT icon
41
Rezolute
RZLT
$479M
$274K 0.07%
84,783
-336,130
-80% -$1.12M
BLIN icon
42
Bridgeline Digital
BLIN
$14.9M
$214K 0.06%
178,003
-482,518
-73% -$685K
SVRE
43
CALL
SaverOne 2014 Ltd
SVRE
$6.02M
$200K 0.05%
+66
New +$1.44M
RVLP
44
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$116K 0.03%
+84,993
New +$123K
NLSPW
45
CALL
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$99K 0.03%
827,421
-500
-0.1% -$121
CYTHW
46
CALL
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
$38K 0.01%
294,431
-500
-0.2% -$489
PRBM.WS
47
CALL
DELISTED
Parabellum Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
PRBM.WS
$38K 0.01%
+589,286
New +$98.4K
ABEO icon
48
Abeona Therapeutics
ABEO
$389M
– –
-201,004
Closed -$1.58M
AMPG icon
49
AmpliTech
AMPG
$140M
– –
-137,372
Closed -$461K
FOCL
50
EDAP TMS S.A.
FOCL
$238M
– –
-627,316
Closed -$4.55M
1
2
3

Similar funds

GFI
Global Frontier Investments Charleston, South Carolina $732M AUM 8.6% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $732M AUM 29.73% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
GIC
GFI Investment Counsel Toronto, Ontario, Canada $731M AUM 3.86% 1-Year Est. Return
CT
Colonial Trust Spartanburg, South Carolina $735M AUM 18% 1-Year Est. Return
TWP
TFO Wealth Partners Maumee, Ohio $735M AUM 21.07% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return
JJBC
James J. Burns & Company Melville, New York $737M AUM 17.98% 1-Year Est. Return

AIGH Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, AIGH Capital Management held 57 positions worth $380M, down 6.8% from $408M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

AIGH Capital Management deployed $34M of net new capital in Q2 2022, opening 15 new positions and adding to 8 existing holdings. Its largest new stake was Transphorm, Inc. Common Stock: 3,778,937 shares worth $14.1M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 36% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Silicon Motion, an estimated $21.9M trimmed.

  • AIGH Capital Management's largest Q2 2022 buy was Transphorm, Inc. Common Stock: 3,778,937 shares worth $14.1M.
  • AIGH Capital Management added most to CalAmp Corp. in Q2 2022, an estimated $3.41M increase.
  • AIGH Capital Management's biggest Q2 2022 reduction was Silicon Motion, cutting an estimated $21.9M.
  • AIGH Capital Management fully exited PDF Solutions in Q2 2022, selling an estimated $24M.
  • AIGH Capital Management's ten largest holdings make up 74% of its $380M portfolio in Q2 2022.
  • AIGH Capital Management opened 15 new positions and closed 10 in Q2 2022.
  • AIGH Capital Management's portfolio value fell 6.8% quarter-over-quarter to $380M.

Based on AIGH Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.